Evidence map›Paper›PMID 38274142›Full record

ArticleEpilepsy & behavior reports2024

Analyses of patients who self-administered diazepam nasal spray for acute treatment of seizure clusters.

Sunita N Misra, Michael R Sperling, Vikram R Rao, Jurriaan M Peters, Patricia Penovich, James Wheless, R Edward Hogan, Charles S Davis, Enrique Carrazana, Adrian L Rabinowicz

Open access · goldAbstract read
In one paragraph

Article in Epilepsy & behavior reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Development ofPharmaceutics · 2024
    Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 9 institutions in 1 country.

Sunita N MisraFormerly of Neurelis, Inc., 3430 Carmel Mountain Rd, Ste 300, San Diego, CA 92121, USA.
Michael R SperlingThomas Jefferson University, 909 Walnut St., Philadelphia, PA 19107, USA.
Vikram R RaoUniversity of California, San Francisco, 400 Parnassus Ave Fl 8, San Francisco, CA 94143, USA.
Jurriaan M PetersBoston Children's Hospital, Harvard Medical School, 300 Longwood Ave, Boston, MA 20115, USA.
Patricia PenovichMinnesota Epilepsy Group, 225 Smith Ave N, St. Paul, MN 55102, USA.
James WhelessLe Bonheur Children's Hospital, University of Tennessee Health Science Center, 49 N Dunlap St, FOB Room 393, Memphis, TN 38105, USA.
R Edward HoganWashington University in St. Louis, 4921 Parkview Pl, St. Louis, MO 63110, USA.
Charles S DavisCSD Biostatistics, Inc., 1005 W Soft Wind Pl, Oro Valley, AZ 85737, USA.
Enrique CarrazanaJohn A. Burns School of Medicine, University of Hawaii, 651 Ilalo St., Honolulu, HI 96813, USA.
Adrian L RabinowiczNeurelis, Inc., 3430 Carmel Mountain Rd, Ste 300, San Diego, CA, 92121, USA.
Neurelis (United States) · USBoston Children's Hospital · USMinnesota Epilepsy Group · USThomas Jefferson University · USUniversity of California, San Francisco · USUniversity of Hawaiʻi at Mānoa · USUniversity of Tennessee Health Science Center · USWashington University in St. Louis · USWest Valley High School · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For acute treatment of seizure clusters in patients with epilepsy, intranasal administration of acute seizure therapies has been shown to provide accessibility and ease of use to care partners as well as the potential for self-administration by patients. Diazepam nasal spray (Valtoco®) was approved by the US Food and Drug Administration for acute treatment of intermittent, stereotypic episodes of frequent seizure activity (ie, seizure clusters, acute repetitive seizures) in patients with epilepsy aged ≥6 years. Self-administration consistent with the prescribing information is feasible and was reported by a subgroup of patients (n = 27 of 163) in a long-term phase 3 safety study. Data regarding self-administration among these patients with seizure clusters are examined here to explore the safety profiles and measures of effectiveness, as well as the quality of life of those who self-treated. In addition, this focused look at patients who self-administered diazepam nasal spray may offer some insights into the characteristics of patients who may be appropriate for self-administration.

Indexed as

Acute repetitive seizureBenzodiazepineIntranasalRescue medicationSeizure emergency

Identifiers

PMID38274142
PMCPMC10808926
OpenAlexW4390511866

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.